6533b7dcfe1ef96bd12734b5
RESEARCH PRODUCT
Mitochondrial defects and neuromuscular degeneration caused by altered expression of Drosophila Gdap1: implications for the Charcot–Marie–Tooth neuropathy
Alexander J. WhitworthFederico V. PallardóMarta Seco-cerveraVíctor López Del AmoMáximo Ibo GalindoJosé Luis García-giménezsubject
Nerve Tissue ProteinsDiseaseDegeneration (medical)BiologyMitochondrionMitochondrial Sizemedicine.disease_causeRetinaCharcot-Marie-Tooth DiseaseGeneticsmedicineAnimalsDrosophila ProteinsHumansMolecular BiologyGenePhylogenyGenetics (clinical)F-Box ProteinsNeurodegenerationNeuromuscular DiseasesGeneral MedicineAnatomymedicine.diseaseMitochondriaCell biologyTissue DegenerationDisease Models AnimalDrosophila melanogasterGene Expression RegulationMitochondrial SizeOxidative stressdescription
One of the genes involved in Charcot-Marie-Tooth (CMT) disease, an inherited peripheral neuropathy, is GDAP1. In this work, we show that there is a true ortholog of this gene in Drosophila, which we have named Gdap1. By up- and down-regulation of Gdap1 in a tissue-specific manner, we show that altering its levels of expression produces changes in mitochondrial size, morphology and distribution, and neuronal and muscular degeneration. Interestingly, muscular degeneration is tissue-autonomous and not dependent on innervation. Metabolic analyses of our experimental genotypes suggest that alterations in oxidative stress are not a primary cause of the neuromuscular degeneration but a long-term consequence of the underlying mitochondrial dysfunction. Our results contribute to a better understanding of the role of mitochondria in CMT disease and pave the way to generate clinically relevant disease models to study the relationship between mitochondrial dynamics and peripheral neurodegeneration.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2014-08-13 | Human Molecular Genetics |